According to miRagen Therapeutics's latest financial reports the company's current revenue is HK$20.1 Million. In 2019 the company made a revenue of HK$34.89 Million a decrease over the revenue in the year 2018 that were of HK$65.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.